May 12, 2026
7:4
For every 4 shares held, investors received 7. The price per share adjusted from $103.00 to $58.86.
The split itself did not change the total investment value.
Middle East Pharmaceutical Industries Company (TADAWUL:4016) operates in the Pharmaceuticals: major industry.
Middle East Pharmaceutical Industries Company company overviewMiddle East Pharmaceutical Industries Company's most recent stock split was on May 12, 2026. It was a 7-for-4 forward split, so shareholders received 7 shares for every 4 they held.
Middle East Pharmaceutical Industries Company has split its stock once. This history records one forward split, on May 12, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Middle East Pharmaceutical Industries Company's 7-for-4 split on May 12, 2026, every 4 shares became 7 shares.
Middle East Pharmaceutical Industries Company has not announced a new split in our records. Its most recent split was on May 12, 2026, less than a year ago. Companies announce splits in advance, and any new TADAWUL:4016 split will appear on this page.
Already premium?